Skip to content Skip to contact
Global Vox Populi

Top Market Research Companies in China Specializing in Healthcare

Explore top healthcare market research companies in China for 2026, offering verified physician panels and patient insights for better business decisions.

Quick answer

For deep medical expertise and proprietary panel access, Global Vox Populi; for large-scale data and clinical trial support, IQVIA; for brand tracking and consumer-led insights, Kantar; and for physician-focused primary research, M3 Global Research.

Selecting the right partner among healthcare market research companies in China requires balancing deep clinical knowledge with the ability to work through a complex, fragmented regulatory and hospital environment. Brands operating in this market face unique challenges, including the necessity of engaging specific physician tiers, understanding local patient pathways, and protecting compliance with stringent data protection standards.

This assessment evaluates seven prominent agencies to help you identify which provider aligns with your specific study requirements. Whether you are conducting a high-stakes clinical trial, a brand health tracking project, or a rare-disease patient study, the choice of partner significantly impacts the quality and reliability of the data retrieved. This guide provides a framework to compare these healthcare market research companies in China by their reach, methodology, and commitment to data integrity.

Top Market Research Companies in China Specializing in Healthcare: rankings and scores

Exhibit 1: Ranking and weighted score (out of 100)

RankProviderBest forWeighted score
1Global Vox PopuliRare-disease patient and specialist recruitment90.5
2IQVIALarge-scale commercial performance tracking89.0
3KantarBrand health tracking and consumer surveys80.0
4SSRI ChinaSpecialized pharmaceutical and KOL research79.5
5M3 Global ResearchLarge-scale physician and professional surveys79.5
6Ipsos HealthcarePatient journey mapping and healthcare trends77.0
7EscalentHuman-centric brand strategy and UX research76.5

Exhibit 2: Provider comparison

ProviderAudience typesVerification methodCertificationsPricing modelPanel size and sourceMinimum project
Global Vox PopuliPhysicians, patients, nurses, payers, and caregiversLicense verification and rolling registration checksISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelinesNot published677,770 healthcare professionals; 2,403,697 patient profiles; 188,560 nurses and allied health professionals (in China; Global Vox Populi panel records, Oct 2026)Not published
IQVIAPhysicians, pharmacists, wholesalers, and payersInternal database verification and site intelligenceNot stated on pages reviewedNot publishedNot publishedNot published
KantarConsumers, patients, and healthcare usersProprietary AI-enabled anti-fraud technologyNot stated on pages reviewedNot publishedNot publishedNot published
SSRI ChinaPhysicians, KOLs, and patientsExpert recruiter verification and clinical experience checksNot stated on pages reviewedNot publishedNot publishedNot published
M3 Global ResearchPhysicians and healthcare professionalsVerification of medical credentials and professional statusNot stated on pages reviewedNot publishedOver 2 million global HCPs (m3globalresearch.com, Oct 2026)Not published
Ipsos HealthcarePatients, citizens, and healthcare professionalsProprietary panel authenticationNot stated on pages reviewedNot publishedNot publishedNot published
EscalentConsumers, patients, and financial service usersNot publishedNot stated on pages reviewedNot publishedNot publishedNot published

Exhibit 3: Capability matrix

ProviderQuantitativeQualitativeOwn panels / sampleHealthcareB2BMulti-country
Global Vox Populi●●●●●●
IQVIA●––●––
Kantar●●●●–●
SSRI China●●–●●–
M3 Global Research●●●●●●
Ipsos Healthcare●●●●–●
Escalent●●–●––

Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).

How we scored these providers

Assess providers based on their ability to deliver actionable, high-quality data while maintaining strict adherence to complex local and international healthcare regulations.

CriterionWeightWhat it means here
Industry Expertise20This measures the agency’s depth of knowledge regarding the Chinese pharmaceutical, medical device, and healthcare delivery systems. Strong expertise includes understanding the nuances of the National Reimbursement Drug List, local hospital procurement processes, and the specific regulatory environment governing clinical research and medical marketing in the country.
Compliance, Certifications and Security20This assesses the agency’s commitment to data protection, including ISO certifications and compliance with local Chinese data security laws and international standards like HIPAA or GDPR. High-scoring firms demonstrate solid processes for managing sensitive patient information, reporting adverse events, and protecting the absolute security of all research participant data.
Target Audience Reach15This evaluates the depth and breadth of the agency’s panel across physician specialties, patient populations, and payers. A superior reach includes the ability to access hard-to-reach sub-specialists and rare-disease patients, supported by granular profiling data that allows for precise targeting and minimizes the risk of irrelevant respondent inclusion.
Research Quality10This examines the rigor applied to questionnaire design, sampling strategies, and data cleaning. High-quality research requires specific protocols to detect straight-lining, identify fraudulent completes, and make sure that the respondents are truly who they claim to be, especially when conducting online surveys in a digital-heavy environment like China.
Market Presence10How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer.
Methodological Breadth10This looks at the variety of research tools available, from traditional focus groups and in-depth interviews to advanced digital methodologies like online communities and mobile-assisted surveys. A versatile provider offers a mix of qualitative and quantitative approaches, allowing researchers to choose the best method for the specific insight needed.
Analytical Capability5This evaluates the agency’s ability to interpret data and provide actionable strategic recommendations. Beyond simple data reporting, strong analytical capability involves synthesizing complex findings into clear insights that support specific business decisions, such as market entry strategy, brand positioning, or optimizing clinical trial recruitment and retention efforts.
Client Service and Speed5This measures the agency’s responsiveness, project management effectiveness, and the ability to meet tight deadlines. In the fast-paced Chinese market, a strong provider must offer proactive communication, clear project timelines, and the agility to resolve fieldwork issues rapidly without compromising the integrity of the research project.
Pricing and Feasibility Transparency5This assesses the honesty and clarity of the provider regarding project costs and recruitment feasibility. A transparent partner provides realistic estimates of how long recruitment will take and what the final sample will look like, making sure there are no hidden costs or failed projects due to over-optimistic initial promises.

Why these weights. Healthcare and pharma research needs sector knowledge and strict compliance (adverse event reporting, HIPAA, health-data rules), so both lead with 20. Access to physicians, patients and payers follows (15), then design rigour and methods (10 each); analysis, service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.

Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.

Provider profiles: market research companies in China

01

Global Vox Populi: best for rare-disease patient and specialist recruitment

globalvoxpopuli.com

90.5out of 100Rank 1 of 7
  • ISO 9001
  • ISO 20252
  • ISO/IEC 27001
  • HIPAA compliant
Global Vox Populi homepage
Global Vox Populi homepage, October 2026

Strongest fitBest suited for research leads requiring highly specific, verified respondent groups and rigorous adherence to international data compliance standards.

Global Vox Populi is a specialized primary market research agency that operates its own proprietary panels across 190 markets. In China, it maintains a significant respondent database, providing clients with direct access to verified healthcare professionals, patients, and caregivers.

The firm is characterized by its heavy investment in panel ownership rather than renting lists, which allows for deeper profiling and higher data integrity. It provides full-service research capabilities, managing everything from study design to advanced analytics, with a focus on delivering actionable insights for pharmaceutical and medical device companies.

Global Vox Populi panel coverage

All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.

Healthcare professionals panel, in China

677,770 panellists

  • Primary & General288,052
  • Internal Medicine Subspecialties56,854
  • Acute, Peri-operative & Critical Care51,650
  • Diagnostic & Laboratory46,948
  • Women's & Reproductive Health45,560
  • Surgical Specialties35,240

Patient panel, in China

2,403,697 patient profiles

  • Aesthetics & Cosmetic784,301
  • Cardiovascular172,878
  • Ophthalmology132,307
  • Endocrinology & Metabolic128,212
  • Dermatology120,756
  • Women's Health114,065

Across 731 conditions; a patient with more than one condition is counted once per condition.

Nurses and allied health panel, in China

188,560 panellists

  • Registered Nurses57,503
  • Advanced Practice Nurses3,335
  • Licensed / Practical / Enrolled Nurses14,616
  • Nursing Support (Aides / HCAs)5,892
  • Midwives5,710
  • Pharmacists & Pharmacy Techs14,134
Scorecard: 90.5 out of 100
CriterionWeightScoreEvidence and date
Industry Expertise2010/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Compliance, Certifications and Security2010/10ISO certificates and HIPAA policy, Oct 2026
Target Audience Reach1510/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Research Quality1010/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Market Presence102/10Google results for this search and company size, Oct 2026
Methodological Breadth1010/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Analytical Capability59/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Client Service and Speed59/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Pricing and Feasibility Transparency59/10Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026
Weighted score10090.5

Core services

  • Proprietary Panel Management: Operates extensive panels including healthcare professionals, patients, and nurses and allied health professionals.
  • Full-Service Research: Provides end-to-end research support, from initial study design and questionnaire development to final data analysis and strategic reporting.
  • Regulatory Compliance: Maintains ISO 9001, ISO 20252, and ISO/IEC 27001 certifications, making sure all research activities meet international and local data protection standards.

Strengths

  • Deep Panel Granularity: Supports low-incidence targeting using 45 to 140 data points per panel member, protecting high precision for niche medical studies.
  • Verified Respondent Quality: Validates clinical members against license records and re-validates on a rolling basis, removing fraudulent entries before data delivery.
  • Comprehensive Panel Reach: Includes 677,770 healthcare professionals, 2,403,697 patient profiles, and 188,560 nurses and allied health professionals specifically within China.

Innovation and technology

  • Digital Quality Controls: Uses device fingerprinting, geo-checks, and AI-driven speeding detection to maintain high data reliability across all digital survey platforms.
  • Proprietary Platform Hosting: Programmes and hosts all surveys on its own internal platform, providing complete control over the respondent experience and data flow.

Impact on businesses

  • Informed Clinical Decisions: Helps life-science clients optimize clinical trial design and patient recruitment through accurate, data-backed insights.
  • Strategic Market Positioning: Enables brands to refine their market access and communication strategies using verified feedback from key opinion leaders and payers.

Types of research

  • Focus groups and in-depth interviews
  • Online and mobile-assisted surveys
  • Ethnographic and patient diary studies
  • Brand health tracking
  • Expert and KOL interviews

Industries covered

  • Pharmaceuticals
  • Medical Devices
  • Healthcare Providers
  • Biotechnology

Why it may fit your brief

The agency is an ideal match for studies needing deep panel profiling and high-quality data in China. Clients looking for a partner that manages its own panels rather than relying on third-party brokers will find this approach minimizes recruitment errors and improves project feasibility.

Request a quoteView case studies

02

IQVIA: best for large-scale commercial performance tracking

iqvia.com

89.0out of 100Rank 2 of 7
IQVIA homepage
IQVIA homepage, October 2026

Strongest fitBest suited for large pharmaceutical companies needing to integrate primary research with massive datasets and clinical trial support.

IQVIA is a large-scale provider that integrates extensive healthcare data, technology, and analytics to support pharmaceutical and life-science companies. Its presence in China is substantial, with specialized teams focused on hospital audit data, market access strategies, and commercial performance analysis.

The firm is well-positioned for complex, data-heavy projects that require a combination of primary research and secondary data modeling. Their approach relies on a vast internal network of information, which they use to help clients work through clinical development and commercial execution.

Scorecard: 89.0 out of 100
CriterionWeightScoreEvidence and date
Industry Expertise2010/10iqvia.com (4 pages reviewed), Oct 2026
Compliance, Certifications and Security209/10iqvia.com (4 pages reviewed), Oct 2026
Target Audience Reach158/10iqvia.com (4 pages reviewed), Oct 2026
Research Quality109/10iqvia.com (4 pages reviewed), Oct 2026
Market Presence1010/10Google results for this search and company size, Oct 2026
Methodological Breadth108/10iqvia.com (4 pages reviewed), Oct 2026
Analytical Capability59/10iqvia.com (4 pages reviewed), Oct 2026
Client Service and Speed57/10iqvia.com (4 pages reviewed), Oct 2026
Pricing and Feasibility Transparency58/10iqvia.com (4 pages reviewed), Oct 2026
Weighted score10089.0

Core services

  • Clinical Development Solutions: Offers full-service clinical trial management, including site identification, patient recruitment optimization, and regulatory documentation support.
  • Market Intelligence and Analytics: Uses proprietary data and predictive modeling to help clients assess market opportunities and benchmark commercial performance.
  • Functional Service Provider (FSP): Provides outsourced teams and expert resources to augment internal client capabilities across clinical and commercial functions.

Strengths

  • Data-Driven Insights: Uses petabytes of proprietary clinical and pharmacy data to provide a clear view of market dynamics and patient outcomes.
  • Clinical Trial Optimization: Uses advanced site intelligence to reduce screen-fail rates and improve recruitment targets within complex clinical environments.

Innovation and technology

  • AI-Powered Platforms: Deploys agentic AI tools like the IQVIA.ai platform to predict clinical outcomes and optimize field force effectiveness.

Impact on businesses

  • Accelerated Asset Success: Helps life-science organizations bring treatments to market faster through intelligent connection of data and analytics.

Types of research

  • Real-world evidence generation
  • Clinical trial site analysis
  • Market access and pricing studies
  • Commercial performance tracking

Industries covered

  • Pharmaceuticals
  • Life Sciences
  • Biotechnology
  • Wholesalers and Retail Pharmacies

Why it may fit your brief

IQVIA fits well for organizations that require a partner with deep institutional knowledge and extensive proprietary data access. Smaller projects or those requiring high-touch qualitative work might find the scale of this provider less focused compared to boutique agencies.

03

Kantar: best for brand health tracking and consumer surveys

kantar.com

80.0out of 100Rank 3 of 7
Kantar homepage
Kantar homepage, October 2026

Strongest fitBest suited for large brands requiring fast, large-scale consumer and patient insights with solid data quality controls.

Kantar is a large-scale insights company that combines global methodology with local expertise. In China, it supports brands with brand health tracking, primary research, and patient experience studies.

The company uses a vast network of proprietary panels and advanced programming tools to deliver fast, reliable insights. Their approach is heavily focused on brand growth, using sophisticated frameworks to help clients understand their position in the market and improve their advertising and product effectiveness.

Scorecard: 80.0 out of 100
CriterionWeightScoreEvidence and date
Industry Expertise208/10kantar.com (4 pages reviewed), Oct 2026
Compliance, Certifications and Security208/10kantar.com (4 pages reviewed), Oct 2026
Target Audience Reach158/10kantar.com (4 pages reviewed), Oct 2026
Research Quality109/10kantar.com (4 pages reviewed), Oct 2026
Market Presence106/10Google results for this search and company size, Oct 2026
Methodological Breadth109/10kantar.com (4 pages reviewed), Oct 2026
Analytical Capability58/10kantar.com (4 pages reviewed), Oct 2026
Client Service and Speed58/10kantar.com (4 pages reviewed), Oct 2026
Pricing and Feasibility Transparency58/10kantar.com (4 pages reviewed), Oct 2026
Weighted score10080.0

Core services

  • Survey Solutions: Provides custom and DIY survey services using advanced programming tools to protect high data quality and respondent engagement.
  • Brand Growth Consulting: Uses frameworks like BrandZ to provide brand valuation and equity research based on extensive consumer data points.
  • Audience Validation: Validates target audiences using AI-enabled panel technology to protect campaign accuracy and digital targeting performance.

Strengths

  • Advanced Anti-Fraud Tech: Uses proprietary Qubed AI with deep neural networks to detect and prevent panel fraud in real time.
  • Global Panel Scale: Provides access to millions of panelists globally through a well-developed, programmatically enabled platform.

Innovation and technology

  • Agile Research Platforms: Operates Kantar Marketplace to combine agile research products with powerful analytics for fast business decision-making.

Impact on businesses

  • Meaningful Brand Growth: Translates human understanding into business outcomes through proprietary frameworks and behavioral science.

Types of research

  • Brand health tracking
  • Consumer and patient surveys
  • Qualitative and quantitative research
  • Digital audience activation

Industries covered

  • Healthcare
  • Media
  • Consumer Goods
  • Retail

Why it may fit your brief

Kantar is excellent for high-volume research and brand tracking. For niche clinical studies requiring highly specific physician profiles, a more specialized healthcare agency might provide deeper access.

04

SSRI China: best for specialized pharmaceutical and KOL research

ssri.com

79.5out of 100Rank 4 of 7
SSRI China homepage
SSRI China homepage, October 2026

Strongest fitBest suited for pharmaceutical firms needing deep KOL engagement and medical affairs support.

SSRI China is a specialized agency that operates exclusively within the pharmaceutical and medical research sectors. With dedicated offices in China, they provide a full range of primary market research, market intelligence, and consulting services.

Their approach is rooted in long-term experience with healthcare professionals, offering deep insights into clinical practice and doctor-patient communication. They are particularly noted for their ability to manage complex fieldwork and provide support for health outcomes research and medical affairs.

Scorecard: 79.5 out of 100
CriterionWeightScoreEvidence and date
Industry Expertise209/10ssri.com (6 pages reviewed), Oct 2026
Compliance, Certifications and Security208/10ssri.com (6 pages reviewed), Oct 2026
Target Audience Reach158/10ssri.com (6 pages reviewed), Oct 2026
Research Quality108/10ssri.com (6 pages reviewed), Oct 2026
Market Presence107/10Google results for this search and company size, Oct 2026
Methodological Breadth107/10ssri.com (6 pages reviewed), Oct 2026
Analytical Capability58/10ssri.com (6 pages reviewed), Oct 2026
Client Service and Speed58/10ssri.com (6 pages reviewed), Oct 2026
Pricing and Feasibility Transparency57/10ssri.com (6 pages reviewed), Oct 2026
Weighted score10079.5

Core services

  • Primary Market Research: Provides full-service research throughout the product lifecycle, from initial market understanding to post-launch tracking and re-positioning.
  • Health Outcomes Research: Supports medical affairs teams with patient outcomes analysis to create materials for academic posters and journal publications.
  • Market Intelligence Support: Offers consulting to solve complex market challenges, using both proprietary databases and external research resources.

Strengths

  • Healthcare Specialization: Focuses exclusively on the pharma and medical sectors, protecting deep understanding of clinical research needs.
  • Expert Fieldwork Operations: Uses long-standing experience in recruiting healthcare professionals for large-scale interviews and surveys.

Innovation and technology

  • Syndicated Data Products: Maintains specialized databases like PatientsMap to provide insights into physician treatment rates and patient information.

Impact on businesses

  • Evidence-Based Promotion: Helps medical affairs teams create solid data-driven materials for promotion to target physicians.

Types of research

  • Physician and KOL studies
  • Patient outcomes research
  • Market intelligence analysis
  • Fieldwork and interview operations

Industries covered

  • Pharmaceuticals
  • Medical Sector
  • Academic Research
  • Healthcare Providers

Why it may fit your brief

SSRI China is a highly focused partner for clinical-heavy research. Brands looking for broader consumer-facing market research might find generalist agencies better aligned with their needs.

05

M3 Global Research: best for large-scale physician and professional surveys

m3globalresearch.com

79.5out of 100Rank 5 of 7
M3 Global Research homepage
M3 Global Research homepage, October 2026

Strongest fitBest suited for projects requiring large-scale physician participation and professional insights.

M3 Global Research operates as a major player in the physician research space, maintaining a large proprietary panel of verified healthcare professionals. In China, they are active in providing quantitative and qualitative research for global pharmaceutical and medical firms.

Their strength lies in their ability to recruit hard-to-reach medical specialists for complex studies. They provide a full range of research services, including data collection and recruitment, helping clients work through the regulatory environment in China through reliable professional feedback.

Scorecard: 79.5 out of 100
CriterionWeightScoreEvidence and date
Industry Expertise209/10m3globalresearch.com (4 pages reviewed), Oct 2026
Compliance, Certifications and Security208/10m3globalresearch.com (4 pages reviewed), Oct 2026
Target Audience Reach159/10m3globalresearch.com (4 pages reviewed), Oct 2026
Research Quality108/10m3globalresearch.com (4 pages reviewed), Oct 2026
Market Presence105/10Google results for this search and company size, Oct 2026
Methodological Breadth108/10m3globalresearch.com (4 pages reviewed), Oct 2026
Analytical Capability57/10m3globalresearch.com (4 pages reviewed), Oct 2026
Client Service and Speed58/10m3globalresearch.com (4 pages reviewed), Oct 2026
Pricing and Feasibility Transparency57/10m3globalresearch.com (4 pages reviewed), Oct 2026
Weighted score10079.5

Core services

  • Physician Recruitment: Reaches a global panel of over 2 million verified healthcare professionals for paid medical research studies.
  • Data Collection Services: Provides full-service fieldwork operations for quantitative and qualitative healthcare studies across many international markets.
  • Market Research Support: Offers project management and support services to help clients design and execute complex multi-market healthcare research.

Strengths

  • Massive Physician Panel: Maintains a verified global panel of over 2 million healthcare professionals, allowing for broad and deep recruitment.
  • Healthcare Specialization: Focuses entirely on the healthcare space, protecting deep familiarity with physician needs and study requirements.

Innovation and technology

  • Panel Management Tools: Uses sophisticated recruitment and verification technologies to maintain panel integrity and engagement.

Impact on businesses

  • Informed Healthcare Trends: Provides insights that help shape the future of healthcare by gathering expert knowledge from professionals.

Types of research

  • Physician surveys
  • Qualitative and quantitative fieldwork
  • Payer research
  • Multi-market healthcare studies

Industries covered

  • Pharmaceuticals
  • Medical Devices
  • Healthcare Consulting
  • Clinical Research

Why it may fit your brief

M3 is a strong partner for quantitative physician research. For studies requiring deep patient-level insights or complex qualitative methodologies, other providers might offer a more comprehensive approach.

06

Ipsos Healthcare: best for patient journey mapping and healthcare trends

ipsos.com

77.0out of 100Rank 6 of 7
Ipsos Healthcare homepage
Ipsos Healthcare homepage, October 2026

Strongest fitBest suited for clients who need to understand broad market trends and patient perceptions alongside specific product research.

Ipsos Healthcare provides full-service research capabilities in China, focusing on both the patient and physician experience. They are well-regarded for their ability to track healthcare trends and provide actionable insights into the quality of care and public health issues.

The firm emphasizes a partnership approach, combining deep local market understanding with global research standards. They offer a diverse range of methodologies, including online communities, brand tracking, and qualitative research, to help clients make informed decisions in a changing environment.

Scorecard: 77.0 out of 100
CriterionWeightScoreEvidence and date
Industry Expertise208/10ipsos.com (4 pages reviewed), Oct 2026
Compliance, Certifications and Security208/10ipsos.com (4 pages reviewed), Oct 2026
Target Audience Reach158/10ipsos.com (4 pages reviewed), Oct 2026
Research Quality108/10ipsos.com (4 pages reviewed), Oct 2026
Market Presence106/10Google results for this search and company size, Oct 2026
Methodological Breadth108/10ipsos.com (4 pages reviewed), Oct 2026
Analytical Capability58/10ipsos.com (4 pages reviewed), Oct 2026
Client Service and Speed57/10ipsos.com (4 pages reviewed), Oct 2026
Pricing and Feasibility Transparency57/10ipsos.com (4 pages reviewed), Oct 2026
Weighted score10077.0

Core services

  • Healthcare Trend Tracking: Conducts global and local studies to track healthcare perceptions, quality of care, and major public health issues.
  • Brand Strategy and Tracking: Offers specialized brand health tracking and market strategy research for healthcare products and services.
  • Qualitative Research: Provides deep qualitative insights through online communities, panels, and expert interviews with doctors and patients.

Strengths

  • Global Research Scale: Uses a vast, authenticated proprietary panel network to deliver consistent information across multiple markets.
  • Systemic Insight Generation: Produces large-scale reports that provide context on healthcare system perceptions and shifting public attitudes.

Innovation and technology

  • AI-Driven Insights: Uses AI technologies to process data from surveys, social media, and qualitative sources for faster decision-making.

Impact on businesses

  • Confident Decision Making: Helps clients act faster and bolder by providing accurate and relevant information turned into actionable truth.

Types of research

  • Patient journey mapping
  • Brand health tracking
  • Public opinion polling
  • Physician behavior studies

Industries covered

  • Healthcare
  • Pharmaceuticals
  • Public Sector
  • Medical Devices

Why it may fit your brief

Ipsos is well-suited for organizations that value global consistency and large-scale tracking. For highly localized, niche clinical studies, they may be less specialized than boutique healthcare-only firms.

07

Escalent: best for human-centric brand strategy and UX research

escalent.co

76.5out of 100Rank 7 of 7
Escalent homepage
Escalent homepage, October 2026

Strongest fitBest suited for brands looking to combine qualitative human insights with sophisticated behavioral data analysis.

Escalent is an AI-enabled research firm that emphasizes a human-centric approach to understanding market dynamics. In China, it provides full-service research capabilities that help brands translate behavioral data into actionable intelligence.

The firm combines primary research with deep data analytics and behavioral science principles. They are particularly active in helping clients work through brand challenges, customer experience, and market exploration, positioning themselves as partners in driving business growth through deep industry expertise.

Scorecard: 76.5 out of 100
CriterionWeightScoreEvidence and date
Industry Expertise208/10escalent.co (4 pages reviewed), Oct 2026
Compliance, Certifications and Security207/10escalent.co (4 pages reviewed), Oct 2026
Target Audience Reach157/10escalent.co (4 pages reviewed), Oct 2026
Research Quality108/10escalent.co (4 pages reviewed), Oct 2026
Market Presence108/10Google results for this search and company size, Oct 2026
Methodological Breadth109/10escalent.co (4 pages reviewed), Oct 2026
Analytical Capability58/10escalent.co (4 pages reviewed), Oct 2026
Client Service and Speed57/10escalent.co (4 pages reviewed), Oct 2026
Pricing and Feasibility Transparency57/10escalent.co (4 pages reviewed), Oct 2026
Weighted score10076.5

Core services

  • Strategic Market Research: Conducts quantitative and qualitative research to help brands understand human behaviors and translate them into actionable ideas.
  • Data Science and Analytics: Applies deep data analytics to uncover unique customer needs and decision drivers across various industries, including healthcare.
  • UX and CX Research: Focuses on user experience research to build better products and services, making sure brands meet the evolving needs of their customers.

Strengths

  • Behavioral Science Focus: Applies underlying behavioral principles to drive lasting customer engagement and inform better product and plan design.
  • Human-Guided AI: Uses AI responsibly to enhance industry knowledge while maintaining human-in-the-loop review for data quality and transparency.

Innovation and technology

  • AI-Enabled Insights: Integrates AI tools with human expertise to work smarter and deliver deeper insights while protecting ethical standards.

Impact on businesses

  • Actionable Brand Intelligence: Enables businesses to transform complex data into strategies that improve customer relationships and brand positioning.

Types of research

  • Qualitative and quantitative research
  • Behavioral science studies
  • User experience research
  • Brand management analysis

Industries covered

  • Healthcare and Insurance
  • Financial Services
  • Automotive
  • Consumer Goods

Why it may fit your brief

Escalent is a strong choice for projects involving customer journey mapping and brand experience. Providers with a more singular focus on clinical medical research may be better for studies strictly requiring deep physician clinical panels.

How HCP and patient verification actually works in China

Make sure every respondent is verified through mandatory license checks and ongoing professional registration validation.

Mandatory Medical License Verification

For healthcare professionals in China, verification must involve checking national medical license numbers against official government registries. This process makes sure that every participant is a qualified, practicing physician or nurse, rather than a generic survey respondent. Ask your provider for a clear description of their verification process and confirmation that they cross-reference credentials with active clinical databases. If a provider cannot produce proof of this validation, the risk of including non-qualified participants in your study is high, which invalidates the resulting data insights.

Rolling Registration Updates

Professional status in the healthcare sector is dynamic, with practitioners moving between hospitals or changing specialties. A reliable agency implements rolling re-validation protocols, where they verify the status of panel members on a regular basis, not just at the time of initial registration. This prevents the use of stale data. When vetting a partner, ask how often they refresh their panel member details and what happens to respondents whose credentials have expired or are no longer active in the specific field you are researching.

Identity and Fingerprinting

Beyond credentialing, agencies must verify the identity of the person taking the survey. This involves technical measures such as device fingerprinting to detect multiple accounts from the same user, and geo-checks to make sure the participant is actually located in the target region of China. Do not rely solely on self-reported data. Ask for evidence of their technical quality controls, such as trap questions and speed-check algorithms, which prevent automated bots or fraudulent respondents from completing your survey and skewing the final results.

Consent and Data Privacy

Verification also extends to the participant's awareness and consent. In the Chinese healthcare market, transparency regarding how data is used is critical for maintaining professional trust. Make sure that your research partner follows a double opt-in process where participants verify their contact details and consent to the specific study purpose. Ask for documentation of their data privacy policies and proof that they comply with local Chinese regulations regarding the collection and storage of health-related information, which is subject to stricter governance than general consumer data.

How to choose the right provider in China

Select a partner by aligning their specific panel strengths with the clinical or commercial needs of your research project.

  • Define your specific audience: Identify whether you need general practitioners, sub-specialists, or patients with rare conditions. Make sure the provider has a deep, pre-existing panel for that specific group rather than promising to recruit them from scratch.
  • Verify data quality protocols: Ask for the provider's specific methods for weeding out fraudulent completes and bots. A reliable agency will openly discuss their use of identity verification and straight-lining detection.
  • Assess local market experience: Prioritize agencies with a dedicated presence in China. They should understand the local hospital tier system and the nuances of engaging Chinese healthcare professionals.
  • Request feasibility reports early: Before signing a contract, ask for a concrete breakdown of how many qualified respondents they can reach within your required timeframe. Avoid providers that offer vague promises of availability.
  • Confirm compliance standards: Protect the partner follows international research codes and local data protection laws. This is particularly important for studies that handle sensitive patient health information.

Questions to ask before you commission

  1. Can you provide a breakdown of your panel members in China by hospital tier and specialty?
  2. What specific steps do you take to verify the medical licenses of your physician respondents?
  3. How do you handle adverse event reporting in line with international healthcare research guidelines?
  4. Can you show me a case study of a similar project you completed in the Chinese healthcare sector?
  5. What is your process for managing low-incidence recruitment in therapeutic areas like rare diseases?
  6. How does your internal team perform data cleaning to remove bots and fraudulent survey completes?

Common pitfalls to avoid

  • Relying on rented lists: Using agencies that rent panels from third-party brokers often leads to poor data quality and high rates of duplicate or unqualified respondents.
  • Ignoring hospital tiers: Treating all hospital tiers as identical in your research design will lead to inaccurate findings, as the standard of care varies widely across different tiers in China.
  • Overlooking local compliance: Failing to verify that a partner adheres to Chinese data security laws can lead to significant legal risk when handling sensitive health information.
  • Accepting vague feasibility: Agreeing to a project without a concrete number of available, qualified respondents often results in significant delays and failed recruitment efforts.

What a feasibility check should include

Demand a transparent, data-backed feasibility report to confirm that your specific respondent targets are actually reachable.

Define respondent criteria

Specify the exact medical specialty, years of experience, and patient volume required. A proper check confirms whether the provider has enough active members meeting these exact criteria.

Estimate recruitment timelines

Ask for a realistic schedule based on past performance for similar studies. This helps you avoid unrealistic expectations for complex or hard-to-reach audiences.

Assess incidence rates

For rare conditions or niche groups, the feasibility report must account for low incidence. This prevents the common mistake of assuming a large panel size equates to easy access.

Review screening drop-out rates

A good feasibility check predicts how many potential respondents will be screened out. This makes sure your final sample size remains solid even after filtering for quality.

Conclusion

Choosing the right partner from these healthcare market research companies in China requires a clear understanding of your project requirements. For high-stakes clinical research where data integrity is essential, prioritize firms that own their proprietary panels and offer solid verification protocols. For broad commercial tracking or brand health studies, larger agencies with extensive digital reach may provide the speed and scale you need.

Use the provided scorecard to evaluate each provider against your specific goals, paying close attention to their experience with your target audience and their commitment to data security. Remember that the best partner is one that offers transparency in feasibility and a proven track record of working through the unique complexities of the Chinese healthcare system. Invest time in the vetting process to protect your research yields the actionable insights necessary for your strategic business decisions.

Planning research in China? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.

Request a quote View case studies

Frequently asked questions

How do I choose a healthcare market research partner in China?

Choose a partner based on their proprietary panel depth, verification processes, and specific experience within the Chinese healthcare system. Look for agencies that own their panels rather than renting them, and make sure they have a clear understanding of your target audience, whether they are clinicians, patients, or payers. Always request a detailed feasibility report and proof of their compliance with local and international data protection laws before starting any project.

What are the best practices for conducting physician surveys in China?

Best practices include using native-language questionnaires that are culturally relevant, respecting the time constraints of busy clinicians, and making sure that physician recruitment is handled through verified professional channels. It is also important to use mobile-friendly survey platforms, as many doctors in China prefer digital interactions. Providing fair-market value incentives is necessary, but must be balanced with strict adherence to anti-bribery regulations and professional codes of conduct.

How does the Chinese hospital tier system impact market research?

The hospital tier system, which classifies facilities from primary community health centers to tertiary-level institutions, directly impacts the type of clinical practice and patient population you will reach. Research in tertiary hospitals provides insights into complex cases and high-end treatments, while studies in lower-tier facilities focus on primary care and chronic disease management. Your research design must account for these differences to make sure your findings are representative of the specific segment you are targeting.

Are there differences between consumer and healthcare market research in China?

Yes, significant differences exist. Healthcare research requires specialized medical knowledge, rigorous verification of clinical credentials, and adherence to strict regulatory and ethical standards, such as adverse event reporting and patient data privacy. Consumer research is generally broader and focused on sentiment and purchasing behavior. Attempting to apply consumer research methodologies to a healthcare project often leads to data inaccuracies and non-compliance with industry-specific regulations.

What is the role of KOLs in Chinese healthcare market research?

Key Opinion Leaders, or KOLs, are central to understanding treatment trends, clinical adoption, and market access in China. They influence the prescribing behavior of other doctors and are often active in clinical research. Research involving KOLs requires a more qualitative and consultative approach, as they provide high-level strategic insights that go beyond simple quantitative survey data. Engaging them requires a deep understanding of their academic and professional standing within the medical community.

How much does a full-service healthcare research study cost in China?

Costs for a full-service healthcare research study are determined by the complexity of the research design, the difficulty of recruiting your target audience, the methodology used, and the level of analytical support required. Projects involving rare-disease patients or highly specialized clinicians naturally command higher costs due to the recruitment effort. It is best to request a project-specific quote that breaks down recruitment, fieldwork, and analysis to protect transparency and alignment with your budget.

What is the importance of proprietary panels versus rented panels?

Proprietary panels are owned and managed directly by the research agency, which makes sure they have full control over the quality, verification, and profiling of every member. Rented panels are often sourced from third-party brokers, which frequently leads to issues like duplicate respondents who appear on multiple agencies' lists, poor verification of credentials, and lower-quality data. For healthcare research, where accuracy is critical, proprietary panels are the standard for protecting reliable insights.

How is patient data handled in Chinese healthcare research?

Patient data must be handled with extreme care, following both local Chinese data protection laws and international standards like GDPR or HIPAA. This includes making sure that all personal identifiable information is de-identified and that participants have provided informed, revocable consent. Reliable research partners will have strict internal protocols for data encryption, secure storage, and the reporting of any sensitive findings, protecting the protection of participants while maintaining the integrity of the research.

Request research

Let's begin

Ready to hear what your market actually thinks?

Tell us the decision you're trying to make. We'll come back with what we'd field — usually within four business hours.

Brief us on a study